Get the Stockscreener App
6.28
0.64%
0.04
After Hours:
6.28
Compass Pathways Plc Adr stock is traded at $6.28, with a volume of 672.46K.
It is up +0.64% in the last 24 hours and up +13.36% over the past month.
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
See More
Previous Close:
$6.24
Open:
$6.36
24h Volume:
672.46K
Relative Volume:
0.40
Market Cap:
$602.51M
Revenue:
-
Net Income/Loss:
$-144.32M
P/E Ratio:
-2.8807
EPS:
-2.18
Net Cash Flow:
$-105.21M
1W Performance:
-3.68%
1M Performance:
+13.36%
6M Performance:
+57.39%
1Y Performance:
-2.33%
1-Day Range:
$6.28
$6.49
1-Week Range:
$6.19
$6.8389
52-Week Range:
$2.25
$7.085
Compass Pathways Plc Adr Stock (CMPS) Company Profile
Name
Compass Pathways Plc Adr
Sector
Industry
Phone
1-716-676-6461
Address
3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
Compare CMPS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CMPS
Compass Pathways Plc Adr
|
6.28 | 598.67M | 0 | -144.32M | -105.21M | -2.18 |
|
HCA
Hca Healthcare Inc
|
447.04 | 102.99B | 74.37B | 7.31B | 7.29B | 25.88 |
|
THC
Tenet Healthcare Corp
|
210.38 | 18.28B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
27.24 | 15.80B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
EHC
Encompass Health Corp
|
126.13 | 12.73B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
210.68 | 13.28B | 16.08B | 1.20B | 1.06B | 17.82 |
Compass Pathways Plc Adr Stock (CMPS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Feb-27-25 | Initiated | Stifel | Buy |
| Jul-23-24 | Initiated | RBC Capital Mkts | Outperform |
| Apr-01-24 | Initiated | Morgan Stanley | Overweight |
| Dec-12-23 | Initiated | Deutsche Bank | Buy |
| Nov-21-22 | Resumed | Berenberg | Buy |
| Nov-01-22 | Initiated | Loop Capital | Buy |
| Oct-29-21 | Initiated | Oppenheimer | Outperform |
| Jul-13-21 | Initiated | Citigroup | Buy |
| Jun-28-21 | Initiated | Maxim Group | Buy |
| May-11-21 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-01-21 | Initiated | ROTH Capital | Buy |
| Oct-14-20 | Initiated | H.C. Wainwright | Buy |
| Oct-13-20 | Initiated | Berenberg | Buy |
| Oct-13-20 | Initiated | Canaccord Genuity | Buy |
| Oct-13-20 | Initiated | Cowen | Outperform |
| Oct-13-20 | Initiated | Evercore ISI | Outperform |
View All
Compass Pathways Plc Adr Stock (CMPS) Latest News
Compass Pathways soars 62% after December Fair Value signal - Investing.com
COMPASS Pathways (NASDAQ:CMPS) Reaches New 52-Week High After Analyst Upgrade - Defense World
COMPASS Pathways (NASDAQ:CMPS) Price Target Raised to $14.00 at BTIG Research - Defense World
COMPASS Pathways (NASDAQ:CMPS) Sets New 12-Month HighWhat's Next? - MarketBeat
Goldman Sachs Group Inc. Sells 81,540 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
COMPASS Pathways (NASDAQ:CMPS) Trading 6.4% HigherShould You Buy? - MarketBeat
H.C. Wainwright Sticks to Their Buy Rating for COMPASS Pathways (CMPS) - The Globe and Mail
Brokerages Set COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) PT at $16.29 - MarketBeat
Woodline Partners LP Purchases 1,292,927 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Polar Asset Management Partners Inc. Acquires Shares of 229,806 COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Vident Advisory LLC Invests $95,000 in COMPASS Pathways PLC Sponsored ADR $CMPS - Defense World
Driehaus Capital Management LLC Invests $2.01 Million in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
Nantahala Capital Management LLC Purchases 1,829,232 Shares of COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
DAFNA Capital Management LLC Raises Holdings in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives $16.29 Consensus Target Price from Analysts - Defense World
22NW LP Acquires New Position in COMPASS Pathways PLC Sponsored ADR $CMPS - MarketBeat
CMPS Stock Price and Chart — NASDAQ:CMPS - TradingView
HC Wainwright Issues Negative Outlook for CMPS Earnings - Defense World
Analysts Set COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Price Target at $17.00 - Defense World
Compass (CMPS) Q2 Loss Improves 27% - The Globe and Mail
Can Compass Pathways Plc ADR Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com
Compass Pathways appoints former GW Pharmaceuticals CEO to board - Investing.com India
Compass Pathways appoints former GW Pharmaceuticals CEO to board By Investing.com - Investing.com South Africa
HC Wainwright Lowers Earnings Estimates for COMPASS Pathways - Defense World
Equities Analysts Issue Forecasts for CMPS Q1 Earnings - Defense World
CMPS: Riding the Market Waves of Growth and Decline in 2025 - investchronicle.com
COMPASS Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives $17.00 Average Target Price from Brokerages - Defense World
WPP (LON:WPP) Stock Price Down 18.8% Following Analyst Downgrade - Defense World
Helen of Troy (NASDAQ:HELE) Hits New 1-Year Low After Earnings Miss - Defense World
Promising Chinese Stocks To Research – July 9th - Defense World
Epiroc AB (publ) (EPOKY) Projected to Post Earnings on Friday - Defense World
COMPASS Pathways (CMPS) Upgraded to Buy: Here's Why - MSN
This Psychedelic Drug Flopped on Trial Results. Should You Buy the Dip? - Barchart.com
Compass’ stock slips despite psilocybin trial hitting target - Clinical Trials Arena
Compass reports positive Phase 3 results for psilocybin depression drug - Investing.com
Compass Pathways Holds Annual General Meeting By Investing.com - Investing.com South Africa
Compass Pathways Holds Annual General Meeting - Investing.com
COMPASS Pathways (CMPS) Upgraded to Buy: Here's What You Should Know - MSN
Market Highlights: Compass Pathways Plc ADR (CMPS) Ends on a Low Note at 4.04 - DWinneX
Compass Pathways Plc ADR (CMPS) stock: A year of ups and downs - uspostnews.com
Investor’s Delight: Compass Pathways Plc ADR (CMPS) Closes Strong at 3.98, Up 5.57 - DWinneX
Should You Expect Compass Pathways Plc ADR (NASDAQ:CMPS) To Recover From Its 37.44% Gain From Highs? - Marketing Sentinel
CMPS Shares Experience Surge in Value - knoxdaily.com
Taking a Closer Look At Compass Pathways Plc ADR (CMPS) Following Its Recent Trade - knoxdaily.com
Will Compass Pathways Plc ADR (CMPS) meet earnings estimates this quarter? - uspostnews.com
Compass Pathways Plc ADR (CMPS) Shares Are Down -5.56% YTD - Marketing Sentinel
CMPS’s Market Whiplash: -10.58% YTD Decline, 14.00% Rise in 30 Days - investchronicle.com
Compass Pathways appoints new US accounting firm - Investing.com
Netapp Inc (NTAP) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Taking a Closer Look At Cipher Mining Inc (CIFR) Following Its Recent Trade - knoxdaily.com
Compass Pathways Plc Adr Stock (CMPS) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.78%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):